赫赛汀和9-顺式视黄酸联合用药对HER2阳性荷瘤鼠乳腺癌细胞的抑制效应

郎海滨; 糜漫天; 朱俊东

您当前的位置：

首页 >

文章列表页 >

赫赛汀和9-顺式视黄酸联合用药对HER2阳性荷瘤鼠乳腺癌细胞的抑制效应

论著 | 更新时间：2026-01-09

- 赫赛汀和9-顺式视黄酸联合用药对HER2阳性荷瘤鼠乳腺癌细胞的抑制效应
- Synergistic effects of trastuzumab and 9-cis-RA on HER2/neu positive breast cancer cells implanted to nude mice
- 陆军军医大学学报 2008年30卷第17期页码：1601-1603
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R737.9;R977.21;R979.19
- 纸质出版：2008
- 稿件说明：
移动端阅览
郎海滨,糜漫天,朱俊东.赫赛汀和9-顺式视黄酸联合用药对HER2阳性荷瘤鼠乳腺癌细胞的抑制效应[J].陆军军医大学学报(原第三军医大学学报),2008,30(17):1601-1603.

　LANG Hai-bin,MI Man-tian,ZHU Jun-dong.Synergistic effects of trastuzumab and 9-cis-RA on HER2/neu positive breast cancer cells implanted to nude mice[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(17):1601-1603.
郎海滨,糜漫天,朱俊东.赫赛汀和9-顺式视黄酸联合用药对HER2阳性荷瘤鼠乳腺癌细胞的抑制效应[J].陆军军医大学学报(原第三军医大学学报),2008,30(17):1601-1603. DOI：

　LANG Hai-bin,MI Man-tian,ZHU Jun-dong.Synergistic effects of trastuzumab and 9-cis-RA on HER2/neu positive breast cancer cells implanted to nude mice[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(17):1601-1603. DOI：

摘要

目的探讨赫赛汀和9-顺式视黄酸单独和联合用药对HER2阳性乳腺癌细胞周期进程的体内协同抑制效应及其分子机制。方法将处于对数生长期的MCF-7

HER2

细胞皮下注射到BALB/c裸鼠体内，用赫赛汀和9-顺式视黄酸分别单独和联合处理裸鼠移植瘤模型20d，测量各组裸鼠移植瘤的体积大小。利用免疫印记法检测移植瘤细胞HER2、P27、Cyclin E和CDK2蛋白的表达变化。结果赫赛汀和9-顺式视黄酸联合作用组较对照和单独作用组能显著减小HER2阳性乳腺癌细胞裸鼠移植瘤的体积，二者联合运用还能在体内显著改变荷瘤鼠癌细胞HER2、P27、Cyclin E和CDK2的表达。结论联合应用赫赛汀和9-顺式视黄酸可在体内通过对细胞周期相关蛋白的表达进行调控从而达到协同抑制HER2阳性乳腺癌细胞的作用。

Abstract

Objective To observe the synergistic effects of trastuzumab and 9-cis-RA on HER2/neu positive breast cancer cells in vivo. Methods MCF-7 breast cancer cells transfected with exogenous HER2 gene were inoculated into nude mice. Four weeks later

the mice bearing a tumor of approximately 200 mm

in volume were selected to be treated with trastuzumab and/or 9-cis-RA (SC) for 20 d. Then the tumor volume was precisely measured

simultaneously the protein expressions of Cyclin E

CDK2 as well as P27 in the tumor tissues were detected by Western blot assay. Results The combination of trastuzumab and 9-cis-RA synergistically decreased the tumor v

olume

compared with control group and single medication group. Western blot results showed that the Cyclin E and CDK2 expressions were significantly inhibited

while P27 protein expressions were remarkably up-regulated by the co-treatment. Conclusion Trastuzumab and 9-cis-RA could synergistically inhibit the proliferation of HER2 positive breast cancer cells in vivo by influencing the protein expressions of G

phase-related molecules.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

基于中国人群的雌激素受体表达新分层（低/中/高）可更精准地预测HR⁺/HER2^-早期乳腺癌患者的预后

柳氮磺吡啶拮抗电离辐射对乳腺癌转移促进作用的实验研究

跨膜蛋白196对乳腺癌迁移及侵袭能力的影响

环状RNA hsa_circ_0000231与HnRNPK相互作用对乳腺癌增殖、迁移及凋亡的影响

环状RNA circACTN4促进乳腺癌细胞增殖、侵袭和转移的研究